NEW YORK, March 29, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of DS Healthcare Group, Inc. (“DS Healthcare”) (NASDAQ:DSKX) between August 13, 2015 and March 23, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired DS Healthcare securities between August 13, 2015 and March 23, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/ds-healthcare-group.
On March 23, 2016, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity. The Company also announced that the Audit Committee and independent counsel had initiated an investigation in connection with the company’s President, Daniel Khesin, for allegedly fraudulent revenue recognition and equity transaction errors, and that Mr. Khesin had been dismissed. Then on March 29, 2016, the Company announced that the Audit Committee determined the errors totaled approximately $900,000 in reduced revenues, and that as a result, estimated unaudited 2015 fiscal year revenues should be reduced by approximately 6 percent.
If you suffered a loss in DS Healthcare you have until May 31, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/ds-healthcare-group.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



